Neurovascular coupling in patients with relapsing-remitting multiple sclerosis

被引:8
|
作者
Uzuner, Gulnur Tekgol [1 ]
Uzuner, Nevzat [1 ]
机构
[1] Eskisehir Osmangazi Univ, Fac Med, Dept Neurol, TR-26480 Meselik, Eskisehir, Turkey
关键词
Multiple sclerosis; Relapsing-remitting; Transcranial Doppler; Neurovascular coupling; Blood flow velocity; BLOOD-FLOW RESPONSE; TRANSCRANIAL DOPPLER; CEREBROVASCULAR REACTIVITY; DIAGNOSTIC-CRITERIA; STIMULATION; GUIDELINES;
D O I
10.1016/j.clineuro.2016.04.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Also to the inflammatory demyelinating lesions and degenerative process, altered cerebrovascular reactivity or neurovascular coupling (NVC) might be considered as playing another role in the pathogenesis of multiple sclerosis. The objective of this study is to assess the NVC of patients with relapsing-remitting multiple sclerosis (RRMS) during the acute exacerbation period. Patients and methods: Four hundred fifty-eight patients with RRMS and 160 healthy subjects were screened for this study during the last 14 years. We performed transtemporal transcranial Doppler recordings from the P2-segments of both posterior cerebral arteries simultaneously during simple or complex visual stimulation. The NVC was defined as a relative increase of the blood flow velocities as a percentage change of the baseline values during visual stimulation. Results: The NVC to simple visual stimulation was significantly higher in the patients on both sides (37.2 +/- 13.5% and 36.0 +/- 14.8%; right and left side, respectively) from those of the controls (30.9 +/- 9.9% and 30.0 +/- 8.8%; right and left side, respectively) (p < 0.01). Similarly, the NVC to complex visual stimulation was significantly higher in the patients (43.3 +/- 14.1% and 41.7 +/- 13.5%; right and left side, respectively) from those of the controls (38.6 +/- 14.2% and 37.6 +/- 14.1%; right and left side, respectively) (p<0.05). Conclusion: Our results suggest that patients with RRMS during exacerbation period have more reactive neurovascular units in the occipital cortex. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 28
页数:5
相关论文
共 50 条
  • [21] Serum neurofilament in patients with relapsing-remitting multiple sclerosis
    Brandt, A. U.
    Paul, F.
    Freing, A.
    Oberwahrenbrock, T.
    Petzold, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S269 - S270
  • [22] Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis
    Pavan, Karina
    Marangoni, Bruna E. M.
    Schmidt, Kizi B.
    Cobe, Femanda A.
    Matuti, Gabriela S.
    Nishino, Lucia K.
    Thomaz, Rodrigo B.
    Mendes, Maria Fernanda
    Lianza, Sergio
    Tilbery, Charles Peter
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2A) : 332 - 335
  • [23] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [24] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [25] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [26] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [27] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [28] Clinical features of 314 patients with relapsing-remitting multiple sclerosis
    Nogales-Gaete, Jorge
    Aracena, Rodrigo
    Cepeda-Zumaeta, Sergio
    Eloiza, Claudio
    Agurto, Paula
    Diaz, Vannia
    Labbe, Silvia
    Martinez, Sefora
    Flores, Jazmin
    Araya, Casandra
    REVISTA MEDICA DE CHILE, 2014, 142 (05) : 559 - 566
  • [29] Lymphocyte subpopulation in patients with relapsing-remitting multiple sclerosis and SPMS
    Belniak, E.
    Bojarska-Junak, A.
    Mitosek-Szewczyk, K.
    Bartosik-Psujek, H.
    Stehmasiak, Z.
    Rolinski, J.
    MULTIPLE SCLEROSIS, 2007, 13 : S43 - S43
  • [30] Expression of fractalkine in plasma of patients with relapsing-remitting multiple sclerosis
    Pujari, S.
    Suliman, O.
    Woodroofe, N.
    Sharrack, B.
    MULTIPLE SCLEROSIS, 2006, 12 : S219 - S219